Here, to dissect the STAT3 signaling network and to discover key players that may represent feasible targets for ALCL therapies, we performed a time course gene expression profiling experiment following conditional STAT3 knock-down. This evidence concerns the gene STAT3 and anaplastic large cell lymphoma.